Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

Detalles Bibliográficos
Autores principales: Foldi, Julia, Silber, Andrea, Reisenbichler, Emily, Singh, Kamaljeet, Fischbach, Neal, Persico, Justin, Adelson, Kerin, Katoch, Anamika, Horowitz, Nina, Lannin, Donald, Chagpar, Anees, Park, Tristen, Marczyk, Michal, Frederick, Courtney, Burrello, Trisha, Ibrahim, Eiman, Qing, Tao, Bai, Yalai, Blenman, Kim, Rimm, David L., Pusztai, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814070/
https://www.ncbi.nlm.nih.gov/pubmed/35115541
http://dx.doi.org/10.1038/s41523-022-00392-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814070/
https://www.ncbi.nlm.nih.gov/pubmed/35115541
http://dx.doi.org/10.1038/s41523-022-00392-3

Ejemplares similares